AT316563B - Verfahren zur herstellung von neuen 4-amino-6-aryl-pyrimidinen und von deren saeureadditionssalzen - Google Patents
Verfahren zur herstellung von neuen 4-amino-6-aryl-pyrimidinen und von deren saeureadditionssalzenInfo
- Publication number
- AT316563B AT316563B AT00149/73A AT14973A AT316563B AT 316563 B AT316563 B AT 316563B AT 00149/73 A AT00149/73 A AT 00149/73A AT 14973 A AT14973 A AT 14973A AT 316563 B AT316563 B AT 316563B
- Authority
- AT
- Austria
- Prior art keywords
- pyrimidines
- aryl
- amino
- acid
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7821670A | 1970-10-05 | 1970-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT316563B true AT316563B (de) | 1974-06-15 |
Family
ID=22142671
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT858071A AT314540B (de) | 1970-10-05 | 1971-10-05 | Verfahren zur Herstellung von neuen 4-Amino-6-aryl- bzw. 6-heteroaryl-pyrimidinen und von deren Salzen |
| AT605473A AT317229B (de) | 1970-10-05 | 1971-10-05 | Verfahren zur Herstellung von neuen 4-Hydroxy-6-aryl-bzw. 6-heteroarylpyrimidinen |
| AT00149/73A AT316563B (de) | 1970-10-05 | 1971-10-05 | Verfahren zur herstellung von neuen 4-amino-6-aryl-pyrimidinen und von deren saeureadditionssalzen |
| AT00148/73A AT315856B (de) | 1970-10-05 | 1971-10-05 | Verfahren zur herstellung von neuen 4-hydroxy-6-aryl-bzw.6-heteroarylpyrimidinen |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT858071A AT314540B (de) | 1970-10-05 | 1971-10-05 | Verfahren zur Herstellung von neuen 4-Amino-6-aryl- bzw. 6-heteroaryl-pyrimidinen und von deren Salzen |
| AT605473A AT317229B (de) | 1970-10-05 | 1971-10-05 | Verfahren zur Herstellung von neuen 4-Hydroxy-6-aryl-bzw. 6-heteroarylpyrimidinen |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00148/73A AT315856B (de) | 1970-10-05 | 1971-10-05 | Verfahren zur herstellung von neuen 4-hydroxy-6-aryl-bzw.6-heteroarylpyrimidinen |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3707560A (de) |
| JP (2) | JPS5648511B1 (de) |
| AT (4) | AT314540B (de) |
| AU (1) | AU465734B2 (de) |
| BE (1) | BE773484A (de) |
| CA (1) | CA988519A (de) |
| CH (4) | CH554876A (de) |
| DE (2) | DE2165962C2 (de) |
| DK (1) | DK131858C (de) |
| ES (4) | ES395676A1 (de) |
| FI (1) | FI55502C (de) |
| FR (1) | FR2110227B1 (de) |
| GB (2) | GB1373536A (de) |
| NL (1) | NL168511C (de) |
| SE (2) | SE385885B (de) |
| ZA (1) | ZA716615B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3895112A (en) * | 1970-10-05 | 1975-07-15 | Pfizer | Arylpyrimidines in the relaxation of smooth muscle |
| US3859288A (en) * | 1970-10-05 | 1975-01-07 | Pfizer | Arylpyrimidines - inhibitors of platelet aggregation and bronchodilators |
| US3908012A (en) * | 1970-10-05 | 1975-09-23 | Pfizer | Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators |
| US3835132A (en) * | 1972-02-01 | 1974-09-10 | Shell Oil Co | Morpholino-piperazinyl pyrimidines |
| US3950525A (en) * | 1973-06-19 | 1976-04-13 | Pfizer Inc. | Relaxation of smooth muscle in a mammal |
| DE2343419A1 (de) * | 1973-08-29 | 1975-03-13 | Gruenenthal Chemie | Verfahren zur herstellung von pyrimidinderivaten |
| US4725600A (en) * | 1984-07-13 | 1988-02-16 | Fujisawa Pharmaceutical Co., Ltd. | Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent |
| JPH0625157B2 (ja) * | 1988-01-29 | 1994-04-06 | 宇部興産株式会社 | ４―ヒドロキシピリミジン類の製造方法 |
| US4935516A (en) * | 1988-01-29 | 1990-06-19 | Ube Industries, Ltd. | Process for preparing 4-hydroxypyrimidine |
| DE3825647A1 (de) * | 1988-07-28 | 1990-02-01 | Geyer Gmbh & Co Christian | Vorrichtung zur befestigung eines elektrischen schaltgeraetes |
| DE3905364A1 (de) * | 1989-02-22 | 1990-08-23 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool |
| JP2003505384A (ja) | 1999-07-15 | 2003-02-12 | ファーマコピーア，インコーポレーティッド | ブラジキニンｂ１受容体アンタゴニスト |
| US7731985B2 (en) * | 2002-03-15 | 2010-06-08 | Ciba Specialty Chemicals Corporation | 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces |
| AU2003247425B2 (en) * | 2002-05-22 | 2007-03-08 | Amgen Inc. | Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| CA2519265A1 (en) * | 2003-03-28 | 2004-10-07 | Pharmacia & Upjohn Company Llc | Positive allosteric modulators of the nicotinic acetylcholine receptor |
| WO2006113769A1 (en) * | 2005-04-15 | 2006-10-26 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| JP2009164373A (ja) * | 2008-01-08 | 2009-07-23 | Toshiba Corp | 半導体装置 |
| RU2012133475A (ru) * | 2010-01-25 | 2014-03-10 | Схди Фаундейшн, Инк. | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения |
| ES2629194T3 (es) | 2011-08-30 | 2017-08-07 | Chdi Foundation, Inc. | Inhibidores de kinurenina-3-monoxigenasa, composiciones farmacéuticas y métodos de utilización del mismo |
| MX2014002459A (es) | 2011-08-30 | 2014-04-10 | Chdi Foundation Inc | Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodos de uso de los mismos. |
| EP3169684B1 (de) | 2014-07-17 | 2019-06-26 | CHDI Foundation, Inc. | Kombination des kmo inhibitors 6-(3-chloro-4-cyclopropoxyphenyl)pyrimidine-4-carbonsäure mit antiviralem wirkstoff zur behandlung von mit hiv zusammenhängenden neurologischen erkrankungen |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3047462A (en) * | 1959-03-06 | 1962-07-31 | Lab Jacques Logeais Soc D Expl | Quinazolone anti-inflammatory composition |
-
1970
- 1970-10-05 US US78216A patent/US3707560A/en not_active Expired - Lifetime
-
1971
- 1971-09-30 FI FI2734/71A patent/FI55502C/fi active
- 1971-10-01 DK DK480171A patent/DK131858C/da not_active IP Right Cessation
- 1971-10-02 DE DE2165962A patent/DE2165962C2/de not_active Expired
- 1971-10-02 DE DE2149249A patent/DE2149249C3/de not_active Expired
- 1971-10-04 SE SE7112534-8A patent/SE385885B/xx unknown
- 1971-10-04 GB GB3831673A patent/GB1373536A/en not_active Expired
- 1971-10-04 ES ES395676A patent/ES395676A1/es not_active Expired
- 1971-10-04 SE SE7410488A patent/SE390304B/xx unknown
- 1971-10-04 CA CA124,312A patent/CA988519A/en not_active Expired
- 1971-10-04 ZA ZA716615A patent/ZA716615B/xx unknown
- 1971-10-04 GB GB4615871A patent/GB1373535A/en not_active Expired
- 1971-10-05 JP JP7823771A patent/JPS5648511B1/ja active Pending
- 1971-10-05 CH CH1452971A patent/CH554876A/fr not_active IP Right Cessation
- 1971-10-05 NL NLAANVRAGE7113670,A patent/NL168511C/xx not_active IP Right Cessation
- 1971-10-05 CH CH1521472A patent/CH554875A/fr not_active IP Right Cessation
- 1971-10-05 FR FR7135815A patent/FR2110227B1/fr not_active Expired
- 1971-10-05 CH CH772973A patent/CH542218A/fr not_active IP Right Cessation
- 1971-10-05 AT AT858071A patent/AT314540B/de not_active IP Right Cessation
- 1971-10-05 AT AT605473A patent/AT317229B/de not_active IP Right Cessation
- 1971-10-05 AT AT00149/73A patent/AT316563B/de not_active IP Right Cessation
- 1971-10-05 AT AT00148/73A patent/AT315856B/de not_active IP Right Cessation
- 1971-10-05 BE BE773484A patent/BE773484A/xx not_active IP Right Cessation
- 1971-10-05 CH CH1532172A patent/CH554346A/fr not_active IP Right Cessation
- 1971-10-06 AU AU34259/71A patent/AU465734B2/en not_active Expired
-
1973
- 1973-11-02 ES ES420211A patent/ES420211A1/es not_active Expired
- 1973-11-02 ES ES420210A patent/ES420210A1/es not_active Expired
- 1973-11-02 ES ES420209A patent/ES420209A1/es not_active Expired
-
1980
- 1980-08-11 JP JP11016380A patent/JPS5636468A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT351557B (de) | Verfahren zur herstellung von neuen substituierten 3-aminoalkylamino-2-hydroxy-1- phenoxypropanen und von deren saeureadditions- salzen | |
| AT316563B (de) | Verfahren zur herstellung von neuen 4-amino-6-aryl-pyrimidinen und von deren saeureadditionssalzen | |
| AT324584B (de) | Verfahren zur herstellung von neuen o-acyl-lysergolen und deren salzen | |
| AT299944B (de) | Verfahren zur Herstellung von neuen Xanthenen und deren Salzen | |
| AT326658B (de) | Verfahren zur herstellung von neuen derivaten des 1-phenoxy-3-amino-propan-2-ols und deren säureadditionssalzen | |
| AT327923B (de) | Verfahren zur herstellung von neuen chinazolindion-verbindungen und deren salzen | |
| AT325597B (de) | Verfahren zur herstellung von neuen benzobicycloalkanaminen und deren säureadditionssalzen | |
| AT307640B (de) | Verfahren zur Herstellung von neuen 17-Aza-steroiden und deren Salzen | |
| AT310719B (de) | Verfahren zur Herstellung von neuen Amidinen und deren Salzen | |
| AT289061B (de) | Verfahren zur Herstellung von neuen Phenäthylaminderivaten und deren Salzen | |
| AT310762B (de) | Verfahren zur Herstellung von neuen Triazolbenzodiazepin-Derivaten sowie von deren Salzen | |
| AT314527B (de) | Verfahren zur Herstellung von neuen 5-Nitrofuranderivaten und deren Salzen | |
| AT330773B (de) | Verfahren zur herstellung von neuen m-dioxan-5-methylaminen und deren salzen | |
| AT309706B (de) | Verfahren zur Herstellung von neuen basischen 17-Azasteroiden und deren Salzen | |
| AT303734B (de) | Verfahren zur Herstellung von neuen N-Vinylchinolonen sowie deren Salzen | |
| AT310756B (de) | Verfahren zur Herstellung von neuen Cinnolinderivaten und von deren pharmazeutisch zulässigen Salzen | |
| AT308752B (de) | Verfahren zur Herstellung von neuen Cycloalkanochinolonderivaten und deren Salzen | |
| AT323167B (de) | Verfahren zur herstellung von neuen derivaten des 1-phenoxy-3-amino-propan-2-ols und deren säureadditionssalzen | |
| AT320629B (de) | Verfahren zur Herstellung von neuen 5-Nitrofuranderivaten und deren Salzen | |
| AT320630B (de) | Verfahren zur Herstellung von neuen 5-Nitrofuranderivaten und deren Salzen | |
| ATA437174A (de) | Verfahren zur herstellung von neuen diphenylmethoxyathylaminen und deren additionssalzen | |
| ATA437274A (de) | Verfahren zur herstellung von neuen diphenylmethoxyathylaminen und deren additionssalzen | |
| AT319943B (de) | Verfahren zur Herstellung von neuen Chromonen und deren Salzen | |
| AT313908B (de) | Verfahren zur Herstellung von neuen Sulfonylaminopyrimidinen sowie deren Salzen | |
| AT327178B (de) | Verfahren zur herstellung von neuen substituierten benzylaminen und von deren salzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |